Literature DB >> 20150183

Intrinsic sex differences in the early growth hormone responsiveness of sex-specific genes in mouse liver.

Valerie Wauthier1, Aarathi Sugathan, Rosana D Meyer, Alan A Dombkowski, David J Waxman.   

Abstract

Sex differences in liver gene expression are dictated by sex differences in circulating GH profiles. Presently, the pituitary hormone dependence of mouse liver gene expression was investigated on a global scale to discover sex-specific early GH response genes that could contribute to sex-specific regulation of downstream GH targets and to ascertain whether intrinsic sex differences characterize hepatic responses to plasma GH stimulation. Global RNA expression analysis identified two distinct classes of sex-specific mouse liver genes: genes subject to positive regulation (class I) and genes subject to negative regulation by pituitary hormones (class II). Genes activated or repressed in hypophysectomized (Hypox) mouse liver within 30-90 min of GH pulse treatment at a physiological dose were identified as putative direct targets of GH action (early response genes). Intrinsic sex differences in the GH responsiveness of a subset of these early response genes were observed. Notably, 45 male-specific genes, including five encoding transcriptional regulators that may mediate downstream sex-specific transcriptional responses, were induced by GH within 30 min in Hypox male but not Hypox female mouse liver. The early GH response genes were enriched in 29 male-specific targets of the transcription factor myocyte enhancer factor 2, whose activation in hepatic stellate cells is associated with liver fibrosis leading to hepatocellular carcinoma, a male-predominant disease. Thus, the rapid activation by GH pulses of certain sex-specific genes is modulated by intrinsic sex-specific factors, which may be associated with prior hormone exposure (epigenetic mechanisms) or genetic factors that are pituitary-independent, and could contribute to sex differences in predisposition to liver cancer or other hepatic patho-physiologies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20150183      PMCID: PMC2840812          DOI: 10.1210/me.2009-0454

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  60 in total

Review 1.  MEF2: a central regulator of diverse developmental programs.

Authors:  Matthew J Potthoff; Eric N Olson
Journal:  Development       Date:  2007-10-24       Impact factor: 6.868

2.  FoxG1, a member of the forkhead family, is a corepressor of the androgen receptor.

Authors:  Maik Obendorf; Rene Meyer; Konstanze Henning; Youri A Mitev; Jens Schröder; Vladimir K Patchev; Siegmund S Wolf
Journal:  J Steroid Biochem Mol Biol       Date:  2007-03-23       Impact factor: 4.292

3.  Growth hormone regulation of insulin-like growth factor-I gene expression may be mediated by multiple distal signal transducer and activator of transcription 5 binding sites.

Authors:  Satyanaryana Eleswarapu; Zhiliang Gu; Honglin Jiang
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

4.  Liver-specific hepatocyte nuclear factor-4alpha deficiency: greater impact on gene expression in male than in female mouse liver.

Authors:  Minita G Holloway; Gregory D Miles; Alan A Dombkowski; David J Waxman
Journal:  Mol Endocrinol       Date:  2008-02-14

5.  Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases.

Authors:  Sunhwa Hong; Young-Wook Cho; Li-Rong Yu; Hong Yu; Timothy D Veenstra; Kai Ge
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

6.  Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation.

Authors:  Carlo Serra; Daniela Palacios; Chiara Mozzetta; Sonia V Forcales; Ianessa Morantte; Meri Ripani; David R Jones; Keyong Du; Ulupi S Jhala; Cristiano Simone; Pier Lorenzo Puri
Journal:  Mol Cell       Date:  2007-10-26       Impact factor: 17.970

7.  Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma.

Authors:  Xueli Bai; Lihua Wu; Tingbo Liang; Zhiqiang Liu; Junjian Li; Donglin Li; Haiyang Xie; Shengyong Yin; Jun Yu; Qi Lin; Shusen Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-05       Impact factor: 4.553

8.  Role of STAT5a in regulation of sex-specific gene expression in female but not male mouse liver revealed by microarray analysis.

Authors:  Karl H Clodfelter; Gregory D Miles; Valerie Wauthier; Minita G Holloway; Xiaohua Zhang; Paul Hodor; William J Ray; David J Waxman
Journal:  Physiol Genomics       Date:  2007-05-29       Impact factor: 3.107

9.  Attenuated expression of episodic growth hormone-induced CYP2C11 in female rats associated with suboptimal activation of the Jak2/Stat5B and other modulating signaling pathways.

Authors:  Ravindra N Dhir; Chellappagounder Thangavel; Bernard H Shapiro
Journal:  Drug Metab Dispos       Date:  2007-08-06       Impact factor: 3.922

10.  Characterization of three growth hormone-responsive transcription factors preferentially expressed in adult female liver.

Authors:  Ekaterina V Laz; Minita G Holloway; Chong-Sheng Chen; David J Waxman
Journal:  Endocrinology       Date:  2007-04-05       Impact factor: 4.736

View more
  41 in total

1.  Gender, age, body mass index, and IGF-I individually and jointly determine distinct GH dynamics: analyses in one hundred healthy adults.

Authors:  Johannes D Veldhuis; Ferdinand Roelfsema; Daniel M Keenan; Steven Pincus
Journal:  J Clin Endocrinol Metab       Date:  2010-10-06       Impact factor: 5.958

2.  Epigenetic mechanisms involved in developmental nutritional programming.

Authors:  Anne Gabory; Linda Attig; Claudine Junien
Journal:  World J Diabetes       Date:  2011-10-15

3.  Sexual dimorphism of growth hormone in the hypothalamus: regulation by estradiol.

Authors:  Melisande L Addison; Emilie F Rissman
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

4.  Unbiased, genome-wide in vivo mapping of transcriptional regulatory elements reveals sex differences in chromatin structure associated with sex-specific liver gene expression.

Authors:  Guoyu Ling; Aarathi Sugathan; Tali Mazor; Ernest Fraenkel; David J Waxman
Journal:  Mol Cell Biol       Date:  2010-09-27       Impact factor: 4.272

Review 5.  Child health, developmental plasticity, and epigenetic programming.

Authors:  Z Hochberg; R Feil; M Constancia; M Fraga; C Junien; J-C Carel; P Boileau; Y Le Bouc; C L Deal; K Lillycrop; R Scharfmann; A Sheppard; M Skinner; M Szyf; R A Waterland; D J Waxman; E Whitelaw; K Ong; K Albertsson-Wikland
Journal:  Endocr Rev       Date:  2010-10-22       Impact factor: 19.871

6.  Genome-wide analysis of chromatin states reveals distinct mechanisms of sex-dependent gene regulation in male and female mouse liver.

Authors:  Aarathi Sugathan; David J Waxman
Journal:  Mol Cell Biol       Date:  2013-07-08       Impact factor: 4.272

7.  Impact of CUX2 on the female mouse liver transcriptome: activation of female-biased genes and repression of male-biased genes.

Authors:  Tara L Conforto; Yijing Zhang; Jennifer Sherman; David J Waxman
Journal:  Mol Cell Biol       Date:  2012-09-10       Impact factor: 4.272

8.  The KRAB zinc finger protein RSL1 regulates sex- and tissue-specific promoter methylation and dynamic hormone-responsive chromatin configuration.

Authors:  Christopher J Krebs; David C Schultz; Diane M Robins
Journal:  Mol Cell Biol       Date:  2012-07-16       Impact factor: 4.272

9.  Growth hormone receptor antagonist transgenic mice are protected from hyperinsulinemia and glucose intolerance despite obesity when placed on a HF diet.

Authors:  Tianxu Yang; Lara A Householder; Ellen R Lubbers; Edward O List; Katie Troike; Clare Vesel; Silvana Duran-Ortiz; John J Kopchick; Darlene E Berryman
Journal:  Endocrinology       Date:  2014-11-18       Impact factor: 4.736

10.  STAT5 Regulation of Sex-Dependent Hepatic CpG Methylation at Distal Regulatory Elements Mapping to Sex-Biased Genes.

Authors:  Pengying Hao; David J Waxman
Journal:  Mol Cell Biol       Date:  2021-01-25       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.